- Home
- ASBP vs LRE Comparison
ASBP vs LRE Comparison
Compare ASBP & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASBP | LRE |
|---|---|---|
| Founded | 2021 | 2001 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 17.2M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | ASBP | LRE |
|---|---|---|
| Price | $1.19 | $1.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 233.0K | 17.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $1.00 |
| 52 Week High | $2.45 | $2.86 |
Technical Indicators
Market Signals| Indicator | ASBP | LRE |
|---|---|---|
| Relative Strength Index (RSI) | 45.40 | 50.52 |
| Support Level | $0.32 | $1.34 |
| Resistance Level | $1.63 | $1.57 |
| Average True Range (ATR) | 0.15 | 0.10 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 15.49 | 41.18 |
Price Performance
Historical ComparisonAbout ASBP Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.